Peer Review History
| Original SubmissionJune 26, 2024 |
|---|
|
Dear Dr. Weinberg, ACADEMIC EDITOR: While the manuscript demonstrates significant potential, it requires major revisions and further refinement to meet the standards necessary for publication. The subject matter is undoubtedly of interest; however, the reviewers have raised critical concerns that must be thoroughly addressed by the authors. plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Marcelo Arruda Nakazone, M.D., Ph.D. Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed: https://bmjopen.bmj.com/content/13/7/e072293.full In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed. 3. We note that there is identifying data in the Supporting Information file <Supplementary Table 2 .docx>. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws. Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared: -Name, initials, physical address -Ages more specific than whole numbers -Internet protocol (IP) address -Specific dates (birth dates, death dates, examination dates, etc.) -Contact information such as phone number or email address -Location data -ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order) Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants. Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data ) and in the following article: http://www.bmj.com/content/340/bmj.c181.long . Please remove or anonymize all personal information (Name/Initials), ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: No Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: N/A Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** Reviewer #1: This systematic review on outcomes and complications in nonagenarians undergoing cardiac surgery addresses a relevant and timely topic. It provides important insights into mortality rates, complications, and hospital stays in this age group. However, there are several areas where the manuscript could be improved. Strengths: The topic is highly pertinent given the aging population and increasing number of elderly surgical candidates. The literature search is thorough, covering multiple countries and procedures. PRISMA guidelines were followed. Minor Concerns: The introduction could be streamlined to focus more on the specific gaps in the literature that this review addresses. The rationale for excluding non-English articles and certain cardiac procedures could be more clearly explained, as this may limit the generalizability of findings. The statistical methods are not adequately described. More detail on data synthesis and analysis, particularly handling of heterogeneity (if any) among studies, is needed. The statistical methods used for data synthesis may be described in more detail. While the manuscript mentions the use of descriptive statistics, there is a lack of detail on how these were calculated and whether any meta-analytic techniques were applied. The authors could consider providing a more robust analysis or explaining why certain methods (e.g. meta-analysis) were not feasible. The discussion should more critically evaluate the findings, particularly the high complication rates, and offer a more balanced view on surgical risks and benefits. For example, the implications of the high complication rates could be explored in greater depth, particularly concerning how these might influence surgical decision-making in nonagenarians. The manuscript suggests that age should not be a disqualifying factor for surgery, which is an important point. However, this statement would benefit from a discussion of the balance between risks and benefits, considering patient preferences and quality of life post-surgery. The manuscript identifies a lack of patient-reported outcomes but could suggest how future research might address this gap. There are a few typographical errors and grammatical issues throughout the manuscript. A thorough proofreading would be beneficial. For example, the sentence "From the initial 1015 articles searched, we included twenty-eight studies from eight countries were included" is redundant and should be revised for clarity. Ethical Considerations: A discussion of the ethical implications of surgery in nonagenarians, particularly around informed consent, would be valuable. Reviewer #2: 1. The authors have to make a choice between a systematic and a scoping review that they seem to assimilate (even in title) but which are two different type of studies with different aim and methodology. Munn, Z., Peters, M.D.J., Stern, C. et al. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol 18, 143 (2018). https://doi.org/10.1186/s12874-018-0611-x. 2. One strength of the study is the extended review of literature and the rigorous methodology deployed to perform the analysis since out of 1015 articles searches (with no restriction on study design or date of publication), the authors included 28 studies from 8 countries (most of them issued from US centers) and totalizing a sample size of 6411 patients. However, the majority of those papers are older than 10 years and certainly do not reflect medical practice in the current era where endovascular procedures has become the main treatment carrier in nonagenarian patients in all domains of cardiovascular diseases including structural valve pathology. Those papers totalize 17% of the overall population but it is not specified how did the authors ensure that patients included in the more recent studies of Khalid, Zack and Elgendy, did not already appear in previous published studies from US. Therefore, in the current review, the probability for one patient to have been reported at least twice is significant. 3. Since a scoping review focuses on the importance of one specified subject in the literature, it is expected that the outcome would relate on one bibliometric index such as the annual incidence of papers related to the subject under study. Instead the authors have used traditional clinical outcomes such as in-hospital mortality, morbidity and length of stay. It even appears that they may have discarded some relevant papers which did not included those clinical outcomes. This is deeply confounding. If they authors aim to perform a systematic review or a metanalysis of the clinical outcomes of cardiac surgery in nonagenarian patients, then the title must be changed as well as the paper has to be deeply revised accordingly. 4. The discussion and interpretation reflect more the author’s belief than the result that they present. Based on those results I would rather assume that the relatively seldom number of papers found in the literature concerning cardiac surgery in nonagenarian patients is a marker of the reluctance to propose chest opening and CPB to frail patients with limited life expectancy. Most of them would probably deny it anyway unless they have the feeling of an imminent death or, most likely, even though. If the well-looking conclusion (not to deny cardiac surgery because of patient’s age only) seems quite reasonable, it is hardly supported by the presented results for a 10% mortality rate for elective procedures is not deemed acceptable in today standards of cardiac surgery. Reviewer #3: The authors present a scoping review of the literature to look at the outcomes of cardiac surgery in nonagenarians. They have published their protocol and registered the review. The standard of English is generally good although there are scattered typos and grammatical errors that require a thorough check through the paper (e.g. line 138, redundant "The"s). The following comments are designed to help the authors address some conflicts between protocol and paper. 1. There is differing definitions of the Population. In some sections, it is >90y, in others 90-99. Clarify which - and in cases where papers presented mixed data, how this was resolved 2. The paper suggests it will include grey literature, but largely excludes by design the large national registries that might describe this information (e.g., although outside the search dates, the SWEDEHEART registry of nonagenarians published recently) 3. Line 148 - please clarify, were full papers translated? 4. Line 151 - please clarify, this sentence is ambiguous 5. Line 156 - centenarians included here 6. Line 159 - lots of procedures not in the search criteria 7. Information sources are not outlined as per PRISMA giuidelines - how were authors contacted etc 8. Line 193 - not clear how two reviewers can agree on four and five studies and end with nine studies? Surely agreement would mean including just four studies (and one that was not independently agreed on) 9. Line 239 - PPI is possible even in reviews 10. Ref 23 - this large study from the STS database likely crosses over some of the patients from the other studies. How did the authors account for this? 11. Line 274 - Figure 2 does not show operations, but this information would be useful and is not shown elsewhere 12. 278 - was additional detail provided in none of the 28 studies? This seems a surprise 13. 289 - was risk stratification also provided e.g. EuroSCORE or STS score? 14. Fig 2 - this figure is complex. Would a bubble plot help to show the same data in a more condensed form, with the size of the bubble indicating the size of the study, x being time and y being survival? 15. Fig 3 - this summary figure was much more helpful and easily to interpret 16. 303-313 - complication rates are very difficult to assess when presented in isolation; some of these are common in any age group, some may be likely in certain procedure groups. A more descriptive narrative of the findings would help the reader. 17. The median time for long term mortality follow up needs to be described as this is very subjective in this age group 18. 383 and 317 report different median stays 19. It was not clear what the outcome of the thematic analysis was. Ideally report this in a separate section. 20. Table 3 - is there any way of summarising how many of the studies included reported this minimum dataset? 21. The statistical method of weighting the different studies is not outlined. Please explain how studies contributed to the averages shown. Overall, I found this study interesting but with several concerns about the precise methodology, as above. I am not an expert in scoping reviews, so have referred to the PRISMA guidance to assess this, but have the impression that this has been largely adhered to. Where there is discrepancy, I have sought to identify where improvements could be made. The relative paucity of experience with scoping reviews in the cardiac surgery literature is not a fault of the authors, but rather one of this reviewer. Nonetheless, the net effect is that the authors must tolerate a more didactic review. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Yousef Tanas Reviewer #2: Yes: Pr Thierry CAUS Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Weinberg, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== The manuscript has been evaluated by two reviewers, and their comments are available below. The reviewers have raised a number of concerns. They feel the manuscript should be clearer in regards to the methodology used for data aggregation and charting and any limitations thereof, especially as it relates to estimates of mortality rate. The specific section on this (lines 349-369) could benefit from a discussion of these limitations. This is particularly important given the large variability in the number of patients in the studies included in your review. Additionally, the reviewers raised issues with the thematic analysis of patient-reported outcome measures and quality-of-life measures. I understand these were not carried out due to lack of data, but I think the text could be clarified regarding this point (especially e.g. lines 211-217) with an acknowledgement that this was a planned analysis that could not in the end be done. Could you please carefully revise the manuscript to address all comments raised? ============================== Please submit your revised manuscript by Aug 04 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Alejandro Torrado Pacheco, Ph.D. Associated Editor PLOS One [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #4: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #4: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #4: Yes ********** Reviewer #1: I appreciate the authors' thorough engagement with all feedback. The manuscript now appears well-prepared. Reviewer #4: some methodological issues, highlighted in attached document, overall very interesting topic and merits publication with minor adjustments. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Yousef Tanas Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Outcomes and complications among nonagenarians undergoing cardiac surgery: a scoping review PONE-D-24-26035R2 Dear Dr. Weinberg, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Dr Redoy Ranjan, MBBS, MRCSEd, Ch.M., MS (CV&TS), FACS Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #4: Yes ********** Reviewer #4: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #4: Yes: Mulai Slave ********** |
| Formally Accepted |
|
PONE-D-24-26035R2 PLOS ONE Dear Dr. Weinberg, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Redoy Ranjan Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .